A phase II trial of induction Erlotinib followed by chemotherapy with Platinum + Pemetrexed +/- Bevacizumab for EGFR mutation-positive non-squamous non-small cell lung cancer patients.
2015 ◽
Vol 33
(15_suppl)
◽
pp. e19039-e19039
Keyword(s):
Phase Ii
◽